# OnCo record zorginstituut-nederland (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/zorginstituut-nederland/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "zorginstituut-nederland" ;
  schema:name "Zorginstituut Nederland (National Health Care Institute)"@en ;
  schema:alternateName "Zorginstituut"@en, "ZIN"@en, "Zorginstituut Nederland"@en, "National Health Care Institute"@en, "Dutch National Health Care Institute"@en ;
  schema:description "The Dutch government body that advises the health minister on what the compulsory basic health insurance covers, including whether each expensive new cancer drug is worth its price."@en ;
  schema:url <https://onco.cc/institutions/zorginstituut-nederland/>, <https://www.zorginstituutnederland.nl> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.zorginstituutnederland.nl>, <https://www.zorginstituutnederland.nl/verzekerde-zorg/e/eigen-risico-zvw>, <https://www.zorginstituutnederland.nl/wat-wij-doen/programmas-en-samenwerkingsverbanden/horizonscan-geneesmiddelen/sluis-voor-dure-geneesmiddelen>, <https://www.zorginstituutnederland.nl/site/binaries/site-content/collections/documents/2024/11/26/beoordelingskader-kosteneffectiviteit-van-zorg/Beoordelingskader+kosteneffectiviteit+van+zorg.pdf>, <https://www.zorginstituutnederland.nl/wat-wij-doen/programmas-en-samenwerkingsverbanden/horizonscan-geneesmiddelen/sluis-voor-dure-geneesmiddelen/overzicht-geneesmiddelen-in-de-sluis>, <https://www.zorginstituutnederland.nl/documenten/2022/12/13/standpunt-tumorinfiltrerende-lymfocyten-til> ;
  schema:addressCountry "NL" ;
  schema:addressLocality "Diemen" ;
  schema:latitude "52.3297"^^xsd:decimal ;
  schema:longitude "4.9596"^^xsd:decimal ;
  onco:related <https://onco.cc/institutions/cbg-meb/>, <https://onco.cc/institutions/iknl/>, <https://onco.cc/institutions/ema/> ;
  onco:drugs <https://onco.cc/drugs/tacquell/> .